Entering text into the input field will update the search result below

Renalytix and Exact Sciences trade higher; Seen as beneficiaries from new CMS rule

Jan. 12, 2021 2:43 PM ETRenalytix Plc (RNLX) Stock, EXAS Stock, TECH StockEXAS, TECH, RNLXBy: Dulan Lokuwithana, SA News Editor
  • Finalization to the Medicare Coverage of Innovative Technology (“MCIT”) rule from CMS will benefit Renalytix (RNLX +3.9%), Exact Sciences (EXAS +3.7%), and Bio-Techne Corporation (TECH -0.6%), Stifel says in an industry update.
  • Proposed in August, the new rule expects to

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
EXAS
--
TECH
--
RNLX
--